WeLeader Biomedical Stock Forecast - Naive Prediction
| 7713 Stock | 70.40 0.90 1.26% |
Momentum 39
Sell Extended
Oversold | Overbought |
Using WeLeader Biomedical hype-based prediction, you can estimate the value of WeLeader Biomedical Co from the perspective of WeLeader Biomedical response to recently generated media hype and the effects of current headlines on its competitors.
The Naive Prediction forecasted value of WeLeader Biomedical Co on the next trading day is expected to be 71.97 with a mean absolute deviation of 0.44 and the sum of the absolute errors of 26.92. WeLeader Biomedical after-hype prediction price | TWD 70.4 |
There is no one specific way to measure market sentiment using hype analysis or a similar predictive technique. This prediction method should be used in combination with more fundamental and traditional techniques such as stock price forecasting, technical analysis, analysts consensus, earnings estimates, and various momentum models.
WeLeader |
WeLeader Biomedical Additional Predictive Modules
Most predictive techniques to examine WeLeader price help traders to determine how to time the market. We provide a combination of tools to recognize potential entry and exit points for WeLeader using various technical indicators. When you analyze WeLeader charts, please remember that the event formation may indicate an entry point for a short seller, and look at other indicators across different periods to confirm that a breakdown or reversion is likely to occur.| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
WeLeader Biomedical Naive Prediction Price Forecast For the 23rd of January
Given 90 days horizon, the Naive Prediction forecasted value of WeLeader Biomedical Co on the next trading day is expected to be 71.97 with a mean absolute deviation of 0.44, mean absolute percentage error of 0.30, and the sum of the absolute errors of 26.92.Please note that although there have been many attempts to predict WeLeader Stock prices using its time series forecasting, we generally do not recommend using it to place bets in the real market. The most commonly used models for forecasting predictions are the autoregressive models, which specify that WeLeader Biomedical's next future price depends linearly on its previous prices and some stochastic term (i.e., imperfectly predictable multiplier).
WeLeader Biomedical Stock Forecast Pattern
WeLeader Biomedical Forecasted Value
In the context of forecasting WeLeader Biomedical's Stock value on the next trading day, we examine the predictive performance of the model to find good statistically significant boundaries of downside and upside scenarios. WeLeader Biomedical's downside and upside margins for the forecasting period are 71.06 and 72.88, respectively. We have considered WeLeader Biomedical's daily market price to evaluate the above model's predictive performance. Remember, however, there is no scientific proof or empirical evidence that traditional linear or nonlinear forecasting models outperform artificial intelligence and frequency domain models to provide accurate forecasts consistently.
Model Predictive Factors
The below table displays some essential indicators generated by the model showing the Naive Prediction forecasting method's relative quality and the estimations of the prediction error of WeLeader Biomedical stock data series using in forecasting. Note that when a statistical model is used to represent WeLeader Biomedical stock, the representation will rarely be exact; so some information will be lost using the model to explain the process. AIC estimates the relative amount of information lost by a given model: the less information a model loses, the higher its quality.| AIC | Akaike Information Criteria | 116.9148 |
| Bias | Arithmetic mean of the errors | None |
| MAD | Mean absolute deviation | 0.4413 |
| MAPE | Mean absolute percentage error | 0.006 |
| SAE | Sum of the absolute errors | 26.9164 |
Predictive Modules for WeLeader Biomedical
There are currently many different techniques concerning forecasting the market as a whole, as well as predicting future values of individual securities such as WeLeader Biomedical. Regardless of method or technology, however, to accurately forecast the stock market is more a matter of luck rather than a particular technique. Nevertheless, trying to predict the stock market accurately is still an essential part of the overall investment decision process. Using different forecasting techniques and comparing the results might improve your chances of accuracy even though unexpected events may often change the market sentiment and impact your forecasting results.WeLeader Biomedical Estimiated After-Hype Price Prediction Volatility
As far as predicting the price of WeLeader Biomedical at your current risk attitude, this probability distribution graph shows the chance that the prediction will fall between or within a specific range. We use this chart to confirm that your returns on investing in WeLeader Biomedical or, for that matter, your successful expectations of its future price, cannot be replicated consistently. Please note, a large amount of money has been lost over the years by many investors who confused the symmetrical distributions of Stock prices, such as prices of WeLeader Biomedical, with the unreliable approximations that try to describe financial returns.
Next price density |
| Expected price to next headline |
WeLeader Biomedical Stock Price Prediction Analysis
Have you ever been surprised when a price of a Company such as WeLeader Biomedical is soaring high without any particular reason? This is usually happening because many institutional investors are aggressively trading WeLeader Biomedical backward and forwards among themselves. Have you ever observed a lot of a particular company's price movement is driven by press releases or news about the company that has nothing to do with actual earnings? Usually, hype to individual companies acts as price momentum. If not enough favorable publicity is forthcoming, the Stock price eventually runs out of speed. So, the rule of thumb here is that as long as this news hype has nothing to do with immediate earnings, you should pay more attention to it. If you see this tendency with WeLeader Biomedical, there might be something going there, and it might present an excellent short sale opportunity.
| Expected Return | Period Volatility | Hype Elasticity | Related Elasticity | News Density | Related Density | Expected Hype |
0.07 | 0.91 | 0.00 | 0.00 | 0 Events / Month | 0 Events / Month | In 5 to 10 days |
| Latest traded price | Expected after-news price | Potential return on next major news | Average after-hype volatility | ||
70.40 | 70.40 | 0.00 |
|
WeLeader Biomedical Hype Timeline
WeLeader Biomedical is presently traded for 70.40on Taiwan OTC Exchange of Taiwan. The entity stock is not elastic to its hype. The average elasticity to hype of competition is 0.0. WeLeader is anticipated not to react to the next headline, with the price staying at about the same level, and average media hype impact volatility is insignificant. The immediate return on the next news is anticipated to be very small, whereas the daily expected return is presently at -0.07%. %. The volatility of related hype on WeLeader Biomedical is about 0.0%, with the expected price after the next announcement by competition of 70.40. Assuming the 90 days trading horizon the next anticipated press release will be in 5 to 10 days. Check out Trending Equities to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as various price indices.WeLeader Biomedical Related Hype Analysis
Having access to credible news sources related to WeLeader Biomedical's direct competition is more important than ever and may enhance your ability to predict WeLeader Biomedical's future price movements. Getting to know how WeLeader Biomedical's peers react to changing market sentiment, related social signals, and mainstream news is a great way to find investing opportunities and time the market. The summary table below summarizes the essential lagging indicators that can help you analyze how WeLeader Biomedical may potentially react to the hype associated with one of its peers.
| HypeElasticity | NewsDensity | SemiDeviation | InformationRatio | PotentialUpside | ValueAt Risk | MaximumDrawdown | |||
| 2516 | New Asia Construction | 0.00 | 0 per month | 1.20 | (0.05) | 2.39 | (1.75) | 13.57 | |
| 6951 | Chin Hsin Environ | 0.00 | 0 per month | 0.62 | (0.09) | 0.68 | (0.93) | 8.64 | |
| 5426 | Cheng Fwa Industrial | 0.00 | 0 per month | 0.00 | (0.13) | 3.00 | (2.57) | 7.96 | |
| 1529 | Klingon Aerospace | 0.00 | 0 per month | 1.72 | 0.13 | 6.08 | (2.79) | 12.71 | |
| 6881 | Ruentex Interior Design | 0.00 | 0 per month | 0.47 | (0.15) | 0.66 | (0.44) | 4.74 | |
| 8098 | 8098 | 0.00 | 0 per month | 0.00 | (0.15) | 3.81 | (4.13) | 13.97 | |
| 1806 | Champion Building Materials | 0.00 | 0 per month | 0.00 | (0.11) | 1.43 | (1.65) | 7.31 | |
| 6179 | Ate Energy International | 0.00 | 0 per month | 0.00 | (0.05) | 4.15 | (3.19) | 13.67 | |
| 4588 | Arch Meter | 0.00 | 0 per month | 1.49 | 0.09 | 6.94 | (2.92) | 16.08 | |
| 6122 | King Polytechnic Engineering | 0.00 | 0 per month | 1.57 | 0.13 | 3.19 | (2.17) | 16.16 |
Other Forecasting Options for WeLeader Biomedical
For every potential investor in WeLeader, whether a beginner or expert, WeLeader Biomedical's price movement is the inherent factor that sparks whether it is viable to invest in it or hold it better. WeLeader Stock price charts are filled with many 'noises.' These noises can hugely alter the decision one can make regarding investing in WeLeader. Basic forecasting techniques help filter out the noise by identifying WeLeader Biomedical's price trends.WeLeader Biomedical Related Equities
One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with WeLeader Biomedical stock to make a market-neutral strategy. Peer analysis of WeLeader Biomedical could also be used in its relative valuation, which is a method of valuing WeLeader Biomedical by comparing valuation metrics with similar companies.
| Risk & Return | Correlation |
WeLeader Biomedical Market Strength Events
Market strength indicators help investors to evaluate how WeLeader Biomedical stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading WeLeader Biomedical shares will generate the highest return on investment. By undertsting and applying WeLeader Biomedical stock market strength indicators, traders can identify WeLeader Biomedical Co entry and exit signals to maximize returns.
WeLeader Biomedical Risk Indicators
The analysis of WeLeader Biomedical's basic risk indicators is one of the essential steps in accurately forecasting its future price. The process involves identifying the amount of risk involved in WeLeader Biomedical's investment and either accepting that risk or mitigating it. Along with some essential techniques for forecasting weleader stock prices, we also provide a set of basic risk indicators that can assist in the individual investment decision or help in hedging the risk of your existing portfolios.
| Mean Deviation | 0.652 | |||
| Standard Deviation | 0.91 | |||
| Variance | 0.828 |
Please note, the risk measures we provide can be used independently or collectively to perform a risk assessment. When comparing two potential investments, we recommend comparing similar equities with homogenous growth potential and valuation from related markets to determine which investment holds the most risk.
Story Coverage note for WeLeader Biomedical
The number of cover stories for WeLeader Biomedical depends on current market conditions and WeLeader Biomedical's risk-adjusted performance over time. The coverage that generates the most noise at a given time depends on the prevailing investment theme that WeLeader Biomedical is classified under. However, while its typical story may have numerous social followers, the rapid visibility can also attract short-sellers, who usually are skeptical about WeLeader Biomedical's long-term prospects. So, having above-average coverage will typically attract above-average short interest, leading to significant price volatility.
Other Macroaxis Stories
Our audience includes start-ups and big corporations as well as marketing, public relation firms, and advertising agencies, including technology and finance journalists. Our platform and its news and story outlet are popular among finance students, amateur traders, self-guided investors, entrepreneurs, retirees and baby boomers, academic researchers, financial advisers, as well as professional money managers - a very diverse and influential demographic landscape united by one goal - build optimal investment portfolios
Story Categories
Currently Trending Categories
Additional Tools for WeLeader Stock Analysis
When running WeLeader Biomedical's price analysis, check to measure WeLeader Biomedical's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy WeLeader Biomedical is operating at the current time. Most of WeLeader Biomedical's value examination focuses on studying past and present price action to predict the probability of WeLeader Biomedical's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move WeLeader Biomedical's price. Additionally, you may evaluate how the addition of WeLeader Biomedical to your portfolios can decrease your overall portfolio volatility.